SV

Seera Veettil Ansari

Director Director DIN 09134559
DIN 09134559 First appointment Feb 2021 Primary industry Non-Profit Organizations
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Seera Veettil Ansari

Data last updated:

Seera Veettil Ansari was a Director at Milan Healthcare Private Limited (2021) and Partner at Qmar Lifesciences Llp (2021). The companies operate in Non-Profit Organizations and Business Services.

DIN 09134559
Primary Designation Director
Industry Non-Profit Organizations
First Appointment 04 Feb 2021

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Milan Healthcare Private Limited U85300KL2021PTC068422
Director05 Apr 20212021₹54.3 Lakh (FY 2025)Active
Partner04 Feb 20212019Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Milan Healthcare Private Limited
Qmar Lifesciences Llp
Premium access

Shareholding and investment profile for Seera Veettil Ansari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Seera Veettil Ansari

Seera Veettil Ansari was first appointed on 04 Feb 2021 as Partner at Qmar Lifesciences Llp.

Seera Veettil Ansari held 2 earlier board appointments: Milan Healthcare Private Limited (Director, 05 Apr 2021 to 10 Jun 2021); Qmar Lifesciences Llp (Partner, 04 Feb 2021 to 16 Oct 2021).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available